| Product Code: ETC10602570 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The import shipments of human papilloma virus vaccine into Bulgaria saw a significant increase in concentration levels in 2024, with a high Herfindahl-Hirschman Index (HHI) indicating a very concentrated Market Top 5 Importing Countries and Market Competition (HHI) Analysis . The top exporting countries to Bulgaria for this vaccine in 2024 were Italy, USA, Sweden, Germany, and UK. Despite a high compound annual growth rate (CAGR) of 20.01% from 2020 to 2024, there was a steep decline in growth rate from 2023 to 2024 at -79.06%. This suggests a shifting landscape in the HPV vaccine Market Top 5 Importing Countries and Market Competition (HHI) Analysis in Bulgaria, potentially influenced by various factors impacting import trends.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bulgaria Human Papilloma Virus Vaccine Market Overview |
3.1 Bulgaria Country Macro Economic Indicators |
3.2 Bulgaria Human Papilloma Virus Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Bulgaria Human Papilloma Virus Vaccine Market - Industry Life Cycle |
3.4 Bulgaria Human Papilloma Virus Vaccine Market - Porter's Five Forces |
3.5 Bulgaria Human Papilloma Virus Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Bulgaria Human Papilloma Virus Vaccine Market Revenues & Volume Share, By Age Group Targeted, 2021 & 2031F |
3.7 Bulgaria Human Papilloma Virus Vaccine Market Revenues & Volume Share, By Formulation Type, 2021 & 2031F |
3.8 Bulgaria Human Papilloma Virus Vaccine Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.9 Bulgaria Human Papilloma Virus Vaccine Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Bulgaria Human Papilloma Virus Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of HPV vaccination in Bulgaria |
4.2.2 Government initiatives to promote HPV vaccination and increase accessibility |
4.2.3 Growing focus on preventive healthcare measures in the country |
4.3 Market Restraints |
4.3.1 High cost of HPV vaccines leading to affordability issues for some segments of the population |
4.3.2 Limited healthcare infrastructure and resources for widespread vaccination programs |
4.3.3 Cultural or religious beliefs affecting acceptance and uptake of HPV vaccination |
5 Bulgaria Human Papilloma Virus Vaccine Market Trends |
6 Bulgaria Human Papilloma Virus Vaccine Market, By Types |
6.1 Bulgaria Human Papilloma Virus Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Bulgaria Human Papilloma Virus Vaccine Market Revenues & Volume, By Vaccine Type, 2021 - 2031F |
6.1.3 Bulgaria Human Papilloma Virus Vaccine Market Revenues & Volume, By Quadrivalent Vaccine, 2021 - 2031F |
6.1.4 Bulgaria Human Papilloma Virus Vaccine Market Revenues & Volume, By Bivalent Vaccine, 2021 - 2031F |
6.2 Bulgaria Human Papilloma Virus Vaccine Market, By Age Group Targeted |
6.2.1 Overview and Analysis |
6.2.2 Bulgaria Human Papilloma Virus Vaccine Market Revenues & Volume, By Children/Adolescents, 2021 - 2031F |
6.2.3 Bulgaria Human Papilloma Virus Vaccine Market Revenues & Volume, By Young Adults, 2021 - 2031F |
6.3 Bulgaria Human Papilloma Virus Vaccine Market, By Formulation Type |
6.3.1 Overview and Analysis |
6.3.2 Bulgaria Human Papilloma Virus Vaccine Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.3 Bulgaria Human Papilloma Virus Vaccine Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.4 Bulgaria Human Papilloma Virus Vaccine Market, By Application Area |
6.4.1 Overview and Analysis |
6.4.2 Bulgaria Human Papilloma Virus Vaccine Market Revenues & Volume, By Cervical Cancer Prevention, 2021 - 2031F |
6.4.3 Bulgaria Human Papilloma Virus Vaccine Market Revenues & Volume, By HPV Type 16 & 18 Prevention, 2021 - 2031F |
6.5 Bulgaria Human Papilloma Virus Vaccine Market, By End Use |
6.5.1 Overview and Analysis |
6.5.2 Bulgaria Human Papilloma Virus Vaccine Market Revenues & Volume, By Public Health Programs, 2021 - 2031F |
6.5.3 Bulgaria Human Papilloma Virus Vaccine Market Revenues & Volume, By School Health Programs, 2021 - 2031F |
7 Bulgaria Human Papilloma Virus Vaccine Market Import-Export Trade Statistics |
7.1 Bulgaria Human Papilloma Virus Vaccine Market Export to Major Countries |
7.2 Bulgaria Human Papilloma Virus Vaccine Market Imports from Major Countries |
8 Bulgaria Human Papilloma Virus Vaccine Market Key Performance Indicators |
8.1 Vaccination coverage rate among the target population |
8.2 Number of educational campaigns conducted to raise awareness about HPV vaccination |
8.3 Rate of HPV-related diseases in Bulgaria |
8.4 Number of healthcare facilities offering HPV vaccination services |
8.5 Percentage of the population vaccinated against HPV |
9 Bulgaria Human Papilloma Virus Vaccine Market - Opportunity Assessment |
9.1 Bulgaria Human Papilloma Virus Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Bulgaria Human Papilloma Virus Vaccine Market Opportunity Assessment, By Age Group Targeted, 2021 & 2031F |
9.3 Bulgaria Human Papilloma Virus Vaccine Market Opportunity Assessment, By Formulation Type, 2021 & 2031F |
9.4 Bulgaria Human Papilloma Virus Vaccine Market Opportunity Assessment, By Application Area, 2021 & 2031F |
9.5 Bulgaria Human Papilloma Virus Vaccine Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Bulgaria Human Papilloma Virus Vaccine Market - Competitive Landscape |
10.1 Bulgaria Human Papilloma Virus Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Bulgaria Human Papilloma Virus Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |